Pharmaceutics

Pharmacology, Toxicology and Pharmaceutical Science

1. Acetic Acid Ethyl Ester 13%
2. Anti-Inflammatory Drug 48%
3. Antibacterial Activity 19%
4. Antibiotics 15%
5. Antidiabetic Agent 10%
6. Antiinfective Agent 62%
7. Antiinflammatory Activity 9%
8. Antimicrobial Agent 20%
9. Antimicrobial Resistance 9%
10. Antioxidant 53%
11. Antioxidant Capacity 20%
12. Antivirus Agent 9%
13. Apigenin 10%
14. Apremilast 11%
15. Ascorbic Acid 8%
16. Baricitinib 9%
17. Bioavailability 74%
18. Biological Marker 14%
19. Breast Cancer 41%
20. Carbon Dioxide 11%
21. Caspase 3 8%
22. Chitosan 37%
23. Ciprofloxacin 8%
24. Clinical Trial 9%
25. Combination Therapy 17%
26. Curcumin 9%
27. Cyclodextrin 12%
28. Cytokine 17%
29. Cytotoxicity 46%
30. Delafloxacin 11%
31. Diabetes Mellitus 15%
32. Diethylene Glycol Monoethyl Ether 8%
33. Differential Scanning Calorimetry 20%
34. Diosmin 11%
35. Diseases 39%
36. Dosage Form 8%
37. Drug Delivery System 36%
38. Drug Development 9%
39. Drug Release 40%
40. Drug Solubility 9%
41. Egg Lecithin 8%
42. Essential Oil 20%
43. Ethyl Cellulose 8%
44. Flavonoid 12%
45. Gallic Acid 9%
46. Glycyrrhizin 8%
47. Gold Nanoparticle 14%
48. High Performance Liquid Chromatography 17%
49. IC50 17%
50. Infection 24%
51. Infectious Agent 11%
52. Inflammation 31%
53. Inflammatory Arthritis 9%
54. Interleukin 6 14%
55. Liposome 13%
56. Lung Cancer 20%
57. Malignant Neoplasm 60%
58. Metformin 9%
59. Methanol 13%
60. Methicillin-Resistant Staphylococcus Aureus 15%
61. microRNA 11%
62. Mole (Insectivora) 8%
63. Nanocarrier 34%
64. Nanoemulsion 31%
65. Nanogel 14%
66. Nanomedicine 9%
67. Nanoparticle 100%
68. Natural Product 16%
69. Neoplasm 17%
70. Nephrotoxicity 8%
71. Non Small Cell Lung Cancer 10%
72. Parkinson's Disease 14%
73. Pharmacodynamics 8%
74. Pharmacokinetic 52%
75. Phytochemical 26%
76. Poloxamer 17%
77. Polyglactin 10%
78. Polyvinyl Alcohol 9%
79. Propylene Glycol 9%
80. Pseudomonas aeruginosa 17%
81. Psoriasis 23%
82. Rat Model 13%
83. Receptor 17%
84. Rheumatoid Arthritis 9%
85. Rutin 10%
86. Scanning Electron Microscopy 20%
87. Silver Nanoparticle 8%
88. Silymarin 9%
89. Simvastatin 10%
90. Skin Infection 9%
91. Solid Lipid Nanoparticle 20%
92. Staphylococcus aureus 15%
93. Surfactant 11%
94. Sustained Release 29%
95. Tablet 34%
96. Transdermal 9%
97. Tumor Necrosis Factor 15%
98. Untranslated RNA 12%
99. Wound Healing 21%
100. Zeta Potential 35%